Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 12:15 AM
Ignite Modification Date:
2025-12-25 @ 10:17 PM
NCT ID:
NCT02014558
Group ID:
EG012
Title:
Gilterinib 300 mg in Expansion Phase
Description:
Participants received 300 mg gilteritinib orally once daily starting on day 1 of cycle 1 and continued in 28-day cycles until disease progression or participant discontinuation in the expansion phase of the study. On day -1 and day 15 of cycle 1, participants also received 2 mg midazolam as a single oral dose.
Deaths Number Affected:
16
Deaths Number At Risk:
None
Serious Number Affected:
14
Serious Number At Risk:
17
Other Number Affected:
16
Other Number At Risk:
17
Study:
NCT02014558
Results Section:
NCT02014558
Adverse Events Module:
NCT02014558